Nagla El-Shitany

10PUBLICATIONS
19CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Time-series analysisInfectious diseasesNanotoxicology, health and safetyExperimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 02, 2022
The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study.

Nagla A El-Shitany, Amina M Bagher, Lenah Saeed Binmahfouz

|Aug 15, 2022
Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity.

Hanadi Abdullah Alwafi, Soad Shaker Ali, Sunil Babu Kotha

|Apr 28, 2021
Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study.

Nagla A El-Shitany, Steve Harakeh, Shaimaa M Badr-Eldin

|Mar 11, 2021
Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-α, BAX, and VEGF immunoexpression via an antioxidant mechanism.

Basma G Eid, Nagla Abd El-Aziz El-Shitany, Thikryat Neamatallah

Pageof 2